Major Ingredients

Trimetazidine Dihydrochloride BP 20mg

Major Functionality

This tablet is indicated for the treatment of Ischaemic heart disease (angina pectoris, sequelae of infarction), adjuvant symptomatic treatment of vertigo and tinnitus, adjuvant treatment of the decline visual acuity and visual field disturbances, presumably of vascular origin.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.